Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT04994483

Public ClinicalTrials.gov record NCT04994483. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 10:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Study Evaluating the Safety and Efficacy of Simufilam 100 mg Tablets in Subjects With Mild-to-Moderate Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A 52-week safety and efficacy study of simufilam (PTI-125) given twice daily to participants with mild-to-moderate Alzheimer's disease (AD) for 52 weeks. Approximately 750 participants will be randomized (1:1) to receive either placebo or 100 mg tablets of simufilam, twice daily, for 52 weeks. Clinic visits will occur 4 weeks after the baseline visit, and then every 12 weeks until the end of the study. The safety of simufilam, and its efficacy in enhancing cognition and slowing cognitive and functional decline will be evaluated.

Study identification

NCT ID
NCT04994483
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cassava Sciences, Inc.
Industry
Enrollment
804 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 87 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2, 2021
Primary completion
Oct 1, 2024
Completion
Oct 1, 2024
Last update posted
May 24, 2025

2021 – 2024

United States locations

U.S. sites
74
U.S. states
25
U.S. cities
68
Facility City State ZIP Site status
MDFirst Research Chandler Arizona 85286
CCT Research - Gilbert Neurology Partners Gilbert Arizona 85297
Xenoscience, Inc. Phoenix Arizona 85004
Advanced Research Center, Inc Anaheim California 92805
Axiom Research, LLC Colton California 92324
ATP Clinical Research, Inc. Costa Mesa California 92626
Sun Valley Research Center, Inc. Imperial California 92251
Senior Clinical Trials Laguna Hills California 92653
Artemis Institute for Clinical Research Riverside California 92503
Syrentis Clinical Research Santa Ana California 92705
Mountain Neurological Research Center Basalt Colorado 81621
Colorado Neurological Research Center, PC Denver Colorado 80210
CT Clinical Research Cromwell Connecticut 06416
Topaz Clinical Research Apopka Florida 32703
Neurology Offices of South Florida Boca Raton Florida 33428
Boynton Beach Medical Research Institute (GMI) Boynton Beach Florida 33437
K2 Medical Research - Clermont Clermont Florida 34711
Arrow Clinical Trials Daytona Beach Florida 32117
Neuropsychiatric Research Center of Southwest Florida Fort Myers Florida 33912
Velocity Clinical Research, Hallandale Beach Hallandale Florida 33009
Galiz Research Hialeah Florida 33016
Infinity Clinical Research - Sunrise Hollywood Florida 33024
CNS Healthcare - Jacksonville Jacksonville Florida 32256
Charter Research Lady Lake Florida 32162
Segal Trials - West Broward Outpatient Site Lauderhill Florida 33319
ClinCloud Maitland Florida 32751
Merritt Island Medical Research, LLC Merritt Island Florida 32952
Central Miami Medical Institute (GMI) Miami Florida 33125
New Horizon Research Center Miami Florida 33165
Luminous Clinical Research Miami Florida 33186
Quantam Clinical Trials Miami Beach Florida 33140
South Florida Research Phase I-IV INC Miami Springs Florida 33166
Suncoast Clinical Research, Inc. New Port Richey Florida 34652
Renstar Medical Research Ocala Florida 34470
Charter Research Orlando Florida 32803
Combined Research Orlando Phase I-IV Orlando Florida 32807
Progressive Medical Research Port Orange Florida 32127
Clinical Research of Brandon, LLC (Tampa) Tampa Florida 33603
Stedman Clinical Trials Tampa Florida 33613
Premier Research Institute at Palm Beach Neurology West Palm Beach Florida 33407
Velocity Clinical Research, Boise Meridian Idaho 83642
Northwestern Medicine Central DuPage Hospital Winfield Illinois 60190
Ascension Via Christi Research Wichita Kansas 67214
Neuro Medical Clinic of Central Louisiana, LLC Alexandria Louisiana 71301
Boston Neuro Research Center North Dartmouth Massachusetts 02747
Clinical Research Professionals Chesterfield Missouri 63005
CCT Research - Papillion Research Center Papillion Nebraska 68046
Advanced Clinical Institute, Inc West Long Branch New Jersey 07764
Albuquerque Neuroscience, Inc Albuquerque New Mexico 87109
Dent Neurologic Institute Amherst New York 14226
Parker Jewish Institute for Health Care & Rehabilitation New Hyde Park New York 11040-1433
Mid Hudson Medical Research New Windsor New York 12553
NY Neurology Associates New York New York 10003
University of Rochester Medical Center - Alzheimer's Disease Care, Research and Education Program Rochester New York 14620
Five Town Neuroscience Research Woodmere New York 11598
Triad Clinical Trials, LLC Greensboro North Carolina 27410
Alzheimer's Memory Center Matthew North Carolina 28105
Insight Clinical Trials LLC Beachwood Ohio 44122
NeuroScience Research Center, LLC Canton Ohio 44718
Dayton Center for Neurological Disorders Centerville Ohio 45459
Summit Research Network, LLC Portland Oregon 97210
Brian Abaluck, LLC Malvern Pennsylvania 19355
Global Medical Institutes/Scranton Medical Institute - Moosic Division Moosic Pennsylvania 18507
Rhode Island Mood & Memory Research Institute East Providence Rhode Island 02914
Palmetto Clinical Research Summerville South Carolina 29485
FutureSearch Trials of Neurology Austin Texas 78731
Senior Adults Specialty Research, Inc Austin Texas 78757
Texas Neurology, PA Dallas Texas 75206
Baylor Scott & White Research Institute Dallas Texas 75231
Mt. Olympus Medical Research, LLC Katy Texas 77450
Grayline Research Center Wichita Falls Texas 76309
Green Mountain Research Institute, Inc. Rutland Vermont 05701
Re:Cognition Health Fairfax Virginia 22031
Memory and Brain Wellness Center at Harborview Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04994483, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 24, 2025 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04994483 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →